{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:35:26Z","timestamp":1791855326704,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dexmedetomidine was found to be protective against traumatic brain injury (TBI) in animal studies and safe for use in previous clinical studies, but whether it improves TBI patient survival remains to be determined. We sought to answer this question by analyzing data from the MIMIC clinical database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data for TBI patients from the MIMIC III and MIMIC IV databases were extracted and divided into a dexmedetomidine group and a control group. In the former group, dexmedetomidine was used for sedation, while in the latter, it was not used. Parameters including patient age, the Acute Physiology score III, the Glasgow Coma Scale, other sedatives used, and pupillary response within 24\u00a0h were employed in propensity score matching to achieve a balance between groups for further analysis. In-hospital survival and 6-month survival were analyzed by Kaplan\u2013Meier survival analysis and compared by log-rank test. Cox regression was used repeatedly for the univariate analysis, the multivariate analysis, the propensity score-matched analysis, and the inverse probability of treatment weighted analysis of survival data. Meanwhile, the influences of hypotension, bradycardia, infection, and seizure on outcome were also analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Different types of survival analyses demonstrated the same trend. Dexmedetomidine significantly improved TBI patient survival. It caused no more incidents of hypotension, infection, and seizure. Hypotension was not correlated with in-hospital mortality, but was significantly correlated with 6-month mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Dexmedetomidine may improve the survival of TBI patients. It should be used with careful avoidance of hypotension.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-022-01822-2","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T07:22:33Z","timestamp":1662103353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Assessment of the effects of dexmedetomidine on outcomes of traumatic brain injury using propensity score analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Jinbu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3192-5511","authenticated-orcid":false,"given":"Qing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"1822_CR1","doi-asserted-by":"publisher","unstructured":"Dewan MC, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018 :1\u201318. https:\/\/doi.org\/10.3171\/2017.10.JNS17352.","DOI":"10.3171\/2017.10.JNS17352"},{"issue":"1","key":"1822_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery. 2017;80(1):6\u201315.","journal-title":"Neurosurgery"},{"issue":"6","key":"1822_CR3","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/neuros\/nyz051","volume":"84","author":"PM Kochanek","year":"2019","unstructured":"Kochanek PM, Tasker RC, Carney N, et al. Guidelines for the Management of Pediatric Severe Traumatic Brain Injury, Third Edition: Update of the Brain Trauma Foundation Guidelines, Executive Summary. Neurosurgery. 2019;84(6):1169\u201378.","journal-title":"Neurosurgery"},{"issue":"4","key":"1822_CR4","doi-asserted-by":"publisher","first-page":"CPG1","DOI":"10.2519\/jospt.2020.0301","volume":"50","author":"CC Quatman-Yates","year":"2020","unstructured":"Quatman-Yates CC, Hunter-Giordano A, Shimamura KK, et al. Physical Therapy Evaluation and Treatment After Concussion\/Mild Traumatic Brain Injury. J Orthop Sports Phys Ther. 2020;50(4):CPG1\u201373.","journal-title":"J Orthop Sports Phys Ther"},{"issue":"5","key":"1822_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.4103\/1673-5374.232529","volume":"13","author":"D Wang","year":"2018","unstructured":"Wang D, Xu X, Wu YG, Lyu L, Zhou ZW, Zhang JN. Dexmedetomidine attenuates traumatic brain injury: action pathway and mechanisms. Neural Regen Res. 2018;13(5):819\u201326.","journal-title":"Neural Regen Res"},{"issue":"1","key":"1822_CR6","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1038\/s41598-018-23003-3","volume":"8","author":"J Wu","year":"2018","unstructured":"Wu J, Vogel T, Gao X, Lin B, Kulwin C, Chen J. Neuroprotective effect of dexmedetomidine in a murine model of traumatic brain injury. Sci Rep. 2018;8(1):4935.","journal-title":"Sci Rep"},{"key":"1822_CR7","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.biopha.2017.08.125","volume":"95","author":"M Shen","year":"2017","unstructured":"Shen M, Wang S, Wen X, et al. Dexmedetomidine exerts neuroprotective effect via the activation of the PI3K\/Akt\/mTOR signaling pathway in rats with traumatic brain injury. Biomed Pharmacother. 2017;95:885\u201393.","journal-title":"Biomed Pharmacother"},{"key":"1822_CR8","unstructured":"Johnson A, Pollard T, & Mark R. MIMIC-III Clinical Database (version 1.4). PhysioNet. 2016.\u00a0https:\/\/physionet.org\/content\/mimiciii\/1.4\/."},{"key":"1822_CR9","unstructured":"Johnson A, Bulgarelli L, Pollard T, Horng S, Celi LA, & Mark R. MIMIC-IV (version 0.4). PhysioNet.,\u00a02020.\u00a0https:\/\/physionet.org\/content\/mimiciv\/0.4\/."},{"issue":"10","key":"1822_CR10","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.","journal-title":"PLoS Med"},{"key":"1822_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/neu.2014.3438","volume":"32","author":"M Majdan","year":"2015","unstructured":"Majdan M, Steyerberg EW, Nieboer D, Mauritz W, Rusnak M, Lingsma HF. Glasgow coma scale motor score and pupillary reaction to predict six-month mortality in patients with traumatic brain injury: comparison of field and admission assessment. J Neurotrauma. 2015;32:101\u20138.","journal-title":"J Neurotrauma"},{"key":"1822_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1089\/08977150260190456","volume":"19","author":"JY Jiang","year":"2002","unstructured":"Jiang JY, Gao GY, Li WP, Yu MK, Zhu C. Early indicators of prognosis in 846 cases of severe traumatic brain injury. J Neurotrauma. 2002;19:869\u201374.","journal-title":"J Neurotrauma"},{"key":"1822_CR13","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1378\/chest.100.6.1619","volume":"100","author":"WA Knaus","year":"1991","unstructured":"Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, Bastos PG, Sirio CA, Murphy DJ, Lotring T, Damiano A. et a: The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100:1619\u201336.","journal-title":"Chest"},{"key":"1822_CR14","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.wneu.2016.06.070","volume":"93","author":"T Okazaki","year":"2016","unstructured":"Okazaki T, Hifumi T, Kawakita K, Nakashima R, Matsumoto A, Shishido H, Ogawa D, Okauchi M, Shindo A, Kawanishi M, Tamiya T, Kuroda Y. Association Between Comorbidities, Nutritional Status, and Anticlotting Drugs and Neurologic Outcomes in Geriatric Patients with Traumatic Brain Injury. World Neurosurg. 2016;93:336\u201340.","journal-title":"World Neurosurg"},{"key":"1822_CR15","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/02699052.2021.1873419","volume":"35","author":"WC Graves","year":"2021","unstructured":"Graves WC, Oyesanya TO, Gormley M, R\u00f8e C, Andelic N, Seel RT, Lu J. Pre- and in-hospital mortality for moderate-to-severe traumatic brain injuries: an analysis of the National Trauma Data Bank (2008\u20132014). Brain Inj. 2021;35:265\u201374.","journal-title":"Brain Inj"},{"issue":"28","key":"1822_CR16","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1002\/sim.6607","volume":"34","author":"PC Austin","year":"2015","unstructured":"Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661\u201379.","journal-title":"Stat Med"},{"issue":"9","key":"1822_CR17","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1002\/acn3.50878","volume":"6","author":"F Li","year":"2019","unstructured":"Li F, Wang X, Zhang Z, Zhang X, Gao P. Dexmedetomidine Attenuates Neuroinflammatory-Induced Apoptosis after Traumatic Brain Injury via Nrf2 signaling pathway. Ann Clin Transl Neurol. 2019;6(9):1825\u201335.","journal-title":"Ann Clin Transl Neurol"},{"issue":"1732","key":"1822_CR18","doi-asserted-by":"publisher","first-page":"146682","DOI":"10.1016\/j.brainres.2020.146682","volume":"1","author":"D Sun","year":"2020","unstructured":"Sun D, Wang J, Liu X, Fan Y, Yang M, Zhang J. Dexmedetomidine attenuates endoplasmic reticulum stress-induced apoptosis and improves neuronal function after traumatic brain injury in mice. Brain Res. 2020;1(1732):146682.","journal-title":"Brain Res"},{"key":"1822_CR19","doi-asserted-by":"publisher","unstructured":"Karakaya D, Cakir-Aktas C, Uzun S, Soylemezoglu F, Mut M. Tailored Therapeutic Doses of Dexmedetomidine in Evolving Neuroinflammation after Traumatic Brain Injury. Neurocrit Care.\u00a02022;36(3):802-814. https:\/\/doi.org\/10.1007\/s12028-021-01381-3.","DOI":"10.1007\/s12028-021-01381-3"},{"key":"1822_CR20","doi-asserted-by":"publisher","unstructured":"Jeffcote T, Weir T, Anstey J, Mcnamara R, Bellomo R, Udy A. The Impact of Sedative Choice on Intracranial and Systemic Physiology in Moderate to Severe Traumatic Brain Injury: A Scoping Review. J Neurosurg Anesthesiol. 2022. https:\/\/doi.org\/10.1097\/ANA.0000000000000836.","DOI":"10.1097\/ANA.0000000000000836"},{"key":"1822_CR21","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3109\/02699052.2013.831130","volume":"27","author":"X Wang","year":"2013","unstructured":"Wang X, Ji J, Fen L, Wang A. Effects of dexmedetomidine on cerebral blood flow in critically ill patients with or without traumatic brain injury: a prospective controlled trial. Brain Inj. 2013;27:1617\u201322.","journal-title":"Brain Inj"},{"issue":"10","key":"1822_CR22","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1080\/02699052.2016.1187289","volume":"30","author":"SS Humble","year":"2016","unstructured":"Humble SS, Wilson LD, Leath TC, Marshall MD, Sun DZ, Pandharipande PP, et al. ICU sedation with dexmedetomidine after severe traumatic brain injury. Brain Inj. 2016;30(10):1266\u201370.","journal-title":"Brain Inj"},{"key":"1822_CR23","doi-asserted-by":"publisher","first-page":"e2986","DOI":"10.7717\/peerj.2986","volume":"5","author":"Q Tang","year":"2017","unstructured":"Tang Q, Wu X, Weng W, Li H, Feng J, Mao Q, et al. The preventive effect of dexmedetomidine on paroxysmal sympathetic hyperactivity in severe traumatic brain injury patients who have undergone surgery: a retrospective study. PeerJ. 2017;5:e2986.","journal-title":"PeerJ"},{"issue":"4","key":"1822_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/jcpt.13389","volume":"46","author":"V Bilodeau","year":"2021","unstructured":"Bilodeau V, Saavedra-Mitjans M, Frenette AJ, Burry L, Albert M, Bernard F, et al. Safety of dexmedetomidine for the control of agitation in critically ill traumatic brain injury patients: a descriptive study. J Clin Pharm Ther. 2021;46(4):1020\u20136.","journal-title":"J Clin Pharm Ther"},{"key":"1822_CR25","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol. 2004;57:1288\u201394.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01822-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-022-01822-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-022-01822-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T07:22:51Z","timestamp":1662103371000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-022-01822-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1186\/s12871-022-01822-2","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"24 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author Jinbu Xu is qualified to use the data in MIMIC databases (certificate number: 25508977). The use of data adhered to ethical guidelines, and no further ethical approvals were needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Both authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}